Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01279031 · ClinicalTrials.gov registry record · Phase 4

Randomized Comparison of the Abbott WHITESTAR Signature System With Ellips Tranversal Ultrasound vs. the Alcon Infiniti With the Ozil Torsional Handpiece in Phacoemulsification: A Contralaterally-Controlled Trial

A Phase 4 study of Astigmatism and Cataracts, sponsored by Innovative Medical.

Completed
Registry status
Phase 4
Development phase
25
Enrollment target
1
Study location

NCT01279031: Completed Phase 4 study of Astigmatism and Cataracts, sponsored by Innovative Medical.

NCT01279031 is a Phase 4 study of Astigmatism and Cataracts that has completed, run by Innovative Medical. The registered enrollment target is 25 participants, below the 105-participant average among 31 other Astigmatism trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01279031, a Phase 4 study of Astigmatism and Cataracts, has completed, sponsored by Innovative Medical.

COMPLETED
Registry status
Phase 4
Development phase
25 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to look at the outcomes of your vision after your cataract surgery based on two different types of equipment that will be used during your surgery.

Conditions Studied

Interventions

  • DEVICE Abbott WHITESTAR Signature System with Ellips Transversal Ultrasound
  • DEVICE Alcon Infiniti wiht the OZIL Torsional Handpiece

Study Locations (1)

California

  • Kerry Assil - Beverly Hills

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2011-10
Est. Completion 2012-01
Phase Phase 4
Innovative Medical

44 total trials

What the finished NCT01279031 record still lists

NCT01279031 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 105-participant average among 31 other Astigmatism trials with a reported enrollment target (76% lower).

The record links to 2 conditions, with Astigmatism appearing as the primary indexed condition, and to 2 interventions - of which Abbott WHITESTAR Signature System with Ellips Transversal Ultrasound is the first listed.

NCT01279031 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT01279031 about?

NCT01279031 is a clinical study titled "Randomized Comparison of the Abbott WHITESTAR Signature System With Ellips Tranversal Ultrasound vs. the Alcon Infiniti With the Ozil Torsional Handpiece in Phacoemulsification: A Contralaterally-Controlled Trial". The purpose of this study is to look at the outcomes of your vision after your cataract surgery based on two different types of equipment that will be used during your surgery.

What is the current status of trial NCT01279031?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 25 participants. The study started on 2011-10. Estimated completion is 2012-01.

What conditions does trial NCT01279031 study?

This clinical trial studies the following conditions: Astigmatism, Cataracts.

What interventions are being tested in trial NCT01279031?

The interventions under investigation include: Abbott WHITESTAR Signature System with Ellips Transversal Ultrasound (DEVICE), Alcon Infiniti wiht the OZIL Torsional Handpiece (DEVICE).

Who is sponsoring clinical trial NCT01279031?

This trial is sponsored by Innovative Medical, which has 44 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01279031 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Astigmatism

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01279031's enrollment target sits among peer trials

25 29th of 31 higher than 3 of 31 other Astigmatism trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Astigmatism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01166854 · 25 participants

    Characterization of Familial Myopathy and Paget Disease of Bone

  • NCT01913106 · 25 participants · Phase 1

    HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer

  • NCT02138669 · 25 participants · NA

    Intacs Prescription Inserts for Keratoconus Patients

  • NCT02174549 · 25 participants · Phase 1

    Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01279031, the US trial registry maintained by the National Library of Medicine. NCT01279031 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.